Lamotrigine Kit
Product Images NDC 49884-882

14 FDA label images from Par Health Usa, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 49884-882). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Par Health Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lamotrigine (Lamotrigine 1)

Lamotrigine (Lamotrigine 1)
Chemical structure diagram of Lamotrigine, showing its molecular arrangement including multiple rings and chlorine and amino groups.*
FDA Label Image

Lamotrigine (Lamotrigine 2)

Lamotrigine (Lamotrigine 2)
A Kaplan-Meier survival curve comparing failure probability (%) over weeks for Lamotrigine versus placebo. The x-axis represents weeks up to approximately 100, and the y-axis represents failure probability from 0% to 100%. Two curves are shown, one for Lamotrigine and one for placebo, with censored data points marked on each curve.*
FDA Label Image

Lamotrigine (Lamotrigine 3)

Lamotrigine (Lamotrigine 3)
A line graph showing failure probability (%) over weeks (0 to 80) comparing Lamotrigine and placebo. Two stepwise lines represent failure probability trends for Lamotrigine and placebo groups. Points marked with '+' indicate censored data. The graph illustrates differences in failure probability between Lamotrigine and placebo over time.*
FDA Label Image

Lamotrigine Odt (Lamotrigine 4)

Lamotrigine Odt (Lamotrigine 4)
Illustration showing Lamotrigine orally disintegrating tablets in four strengths with corresponding imprint details: 25 mg white tablet imprinted with NT on one side and 123 on the other; 50 mg white tablet imprinted with EP on one side and 191 on the other; 100 mg peach tablet imprinted with E on one side and 432 on the other; 200 mg white tablet imprinted with EP on one side and 433 on the other.*
FDA Label Image

Carton_25_mg-par.jpg (Lamotrigine 5)

Carton_25_mg-par.jpg (Lamotrigine 5)
Lamotrigine 25 mg Orally Disintegrating Tablets Maintenance Pack by Par Health USA, LLC. The packaging indicates 30 Unit-of-Use Tablets, intended for patients already taking Lamotrigine, not for initial titration. The label includes administration instructions and patient guidance to verify the product dispensed.*
FDA Label Image

Carton_50_mg-par.jpg (Lamotrigine 6)

Carton_50_mg-par.jpg (Lamotrigine 6)
Lamotrigine Maintenance Pack 50 mg orally disintegrating tablets from Par Health USA, LLC. The carton contains 30 unit-of-use tablets and is labeled for patients already taking lamotrigine, not for initial titration. It includes detailed instructions for use, reminders for medication adherence, and a medication guide. The NDC on the package is 49884-485-11.*
FDA Label Image

Carton_100_mg-par.jpg (Lamotrigine 7)

Carton_100_mg-par.jpg (Lamotrigine 7)
Lamotrigine Maintenance Pack 100 mg Oral Disintegrating Tablets carton by Par Health USA, LLC. The package contains 30 unit-of-use tablets. The label includes usage instructions, refill reminders, a caution to verify product dispensed, and steps for taking the orally disintegrating tablets. The pack is intended for patients already taking Lamotrigine, not for initial titration.*
FDA Label Image

Carton_200_mg-par.jpg (Lamotrigine 8)

Carton_200_mg-par.jpg (Lamotrigine 8)
Lamotrigine 200 mg orally disintegrating tablets Maintenance Pack by Par Health USA, LLC. The packaging includes 30 unit-of-use tablets and is labeled for patients already taking lamotrigine, not for initial titration. The label features dosing instructions, a caution to verify product dispensed, and step-by-step directions for use.*
FDA Label Image

Blue_titration_kit_outer_a_-_par.jpg (Lamotrigine 9)

Blue_titration_kit_outer_a_-_par.jpg (Lamotrigine 9)
Packaging label for Lamotrigine Orally Disintegrating Tablets Patient Titration Kit by Par Health USA, LLC. The kit includes 21 tablets of 25 mg and 7 tablets of 50 mg. The label provides dosage instructions for weeks 1 to 5, describing tablet frequency and loading instructions for weeks 1 & 2 and 3 & 4. It also includes step-by-step usage instructions with illustrations to open, pull, peel, and place the tablets.*
FDA Label Image

Blue_titration_kit_outer_b_-_par.jpg (Lamotrigine 10)

Blue_titration_kit_outer_b_-_par.jpg (Lamotrigine 10)
Packaging label for Lamotrigine orally disintegrating tablets Patient Titration Kit by Par Health USA, LLC. The label indicates tablet strengths of 25 mg for weeks 3 and 4, and 50 mg for week 5. It includes step-by-step instructions on how to open the carton, remove the tablet, peel backing, and place the tablet on the tongue for dissolution. The package is primarily blue with yellow and white accents and features storage instructions and a barcode.*
FDA Label Image

Green_titration_kit_outer_a_-_par.jpg (Lamotrigine 11)

Green_titration_kit_outer_a_-_par.jpg (Lamotrigine 11)
Packaging label for Lamotrigine Orally Disintegrating Tablets Patient Titration Kit by Par Health USA, LLC. The box includes 42 tablets of 50 mg and 14 tablets of 100 mg. Directions for weeks 1-3 outline the dosing schedule, with instructions on opening, pulling, peeling, and placing the tablets for oral disintegration. The label provides patient guidance and cautions to verify product dispensed.*
FDA Label Image

Green_titration_kit_outer_b_-_par.jpg (Lamotrigine 12)

Green_titration_kit_outer_b_-_par.jpg (Lamotrigine 12)
Packaging label for Lamotrigine Orally Disintegrating Tablets Patient Titration Kit by Par Health USA, LLC. The label shows dosing instructions for weeks 3 to 5, involving 50 mg and 100 mg tablets. It includes instructions on opening, peeling, and placing the tablets orally. The label also provides storage information and warnings about blister condition.*
FDA Label Image

Orange_titration_kit_outer_a_-_par.jpg (Lamotrigine 13)

Orange_titration_kit_outer_a_-_par.jpg (Lamotrigine 13)
Lamotrigine Orally Disintegrating Tablets Patient Titration Kit by Par Health USA, LLC. The carton design includes instructions for weeks 1-2 with 25 mg tablets and weeks 3-4 with 50 mg tablets, along with a blister tray for medication. The kit contains 14 tablets of 25 mg, 14 tablets of 50 mg, and 7 tablets of 100 mg, with detailed instructions for use and a caution to verify product dispensed. The packaging is predominantly orange and white with blue text.*
FDA Label Image

Orange_titration_kit_outer_b-_par.jpg (Lamotrigine 14)

Orange_titration_kit_outer_b-_par.jpg (Lamotrigine 14)
Packaging label for Lamotrigine Orally Disintegrating Tablets Patient Titration Kit by Par Health USA, LLC. The label includes instructions for weeks 3, 4, and 5 dosing with 50 mg and 100 mg tablets. It features step-by-step directions to open, pull, peel, and place the orally disintegrating tablets. The label also provides storage instructions, warnings, and manufacturer information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.